Complete RENB Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
RENB Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 8 peer companies in Healthcare
P/E Ratio
$-0.02
-105.2%
Peer Median: 0.0x
EV/EBITDA
$0.00
-100.0%
Peer Median: 0.1x
P/S Ratio
$0.00
-99.7%
Peer Median: 1.0x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for RENB's business model and current situation.
Multiple Comparison
| Multiple | RENB Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -0.8x | 0.0x | 0.0x | -2035.1% | Undervalued |
| EV/EBITDA | Infinityx | 0.1x | 0.1x | Infinity% | Overvalued |
| P/S Ratio | 303.5x | 1.0x | 1.2x | 30554.1% | Overvalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.05B | 0.0x | 0.0x | 0.9x | |
| $0.06B | 0.0x | 0.1x | 0.0x | |
| $0.05B | 0.0x | 0.0x | 2.8x | |
| $0.06B | 0.0x | 0.0x | 303.5x | |
| $0.06B | 0.0x | 0.0x | 0.0x | |
| $0.05B | 0.0x | 0.0x | 203.0x | |
| $0.06B | 0.0x | 0.0x | 1.2x | |
| $0.06B | 0.0x | 0.0x | 1.0x |